Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 2
1972 3
1973 1
1974 2
1975 4
1977 3
1978 4
1980 1
1981 5
1984 7
1985 3
1986 2
1987 4
1988 5
1989 10
1990 1
1991 7
1992 5
1993 7
1994 9
1995 6
1996 9
1997 12
1998 17
1999 9
2000 8
2001 10
2002 7
2003 9
2004 10
2005 16
2006 16
2007 18
2008 12
2009 15
2010 14
2011 21
2012 17
2013 13
2014 24
2015 20
2016 30
2017 39
2018 23
2019 35
2020 38
2021 50
2022 26
2023 22
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Results by year

Filters applied: . Clear all
Page 1
The conundrum of hot mitochondria.
Macherel D, Haraux F, Guillou H, Bourgeois O. Macherel D, et al. Biochim Biophys Acta Bioenerg. 2021 Feb 1;1862(2):148348. doi: 10.1016/j.bbabio.2020.148348. Epub 2020 Nov 26. Biochim Biophys Acta Bioenerg. 2021. PMID: 33248118 Free article. Review.
It has even been suggested that our own mitochondria could operate under normal conditions at a temperature close to 50 C, something difficult to reconcile with the laws of thermal physics. ...
It has even been suggested that our own mitochondria could operate under normal conditions at a temperature close to 50 C, something …
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898971
RECOMMENDATIONS: Lamotrigine (LTG) should (Level B) and levetiracetam (LEV) and zonisamide (ZNS) may (Level C) be considered in decreasing seizure frequency in adults with new-onset focal epilepsy. LTG should (Level B) and gabapentin (GBP) may (Level C) be considere …
RECOMMENDATIONS: Lamotrigine (LTG) should (Level B) and levetiracetam (LEV) and zonisamide (ZNS) may (Level C) be considered in decre …
Proactive Consultation-Liaison Psychiatry: American Psychiatric Association Resource Document.
Oldham MA, Desan PH, Lee HB, Bourgeois JA, Shah SB, Hurley PJ, Sockalingam S; Council on Consultation-Liaison Psychiatry. Oldham MA, et al. J Acad Consult Liaison Psychiatry. 2021 Mar-Apr;62(2):169-185. doi: 10.1016/j.jaclp.2021.01.005. Epub 2021 Jan 29. J Acad Consult Liaison Psychiatry. 2021. PMID: 33970855 Review.
In 2019, the American Psychiatric Association Council on Consultation-Liaison (C-L) Psychiatry convened a work group to develop a resource document on proactive C-L psychiatry. ...This resource document describes the historical context and modern trends that have gi …
In 2019, the American Psychiatric Association Council on Consultation-Liaison (C-L) Psychiatry convened a work group to develop a res …
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Kanner AM, et al. Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Neurology. 2018. PMID: 29898974
The following should be considered to decrease seizure frequency (Level B): lacosamide, eslicarbazepine, and extended-release topiramate for TRAFE (ezogabine production discontinued); immediate- and extended-release lamotrigine for generalized epilepsy with TR generalized tonic-c …
The following should be considered to decrease seizure frequency (Level B): lacosamide, eslicarbazepine, and extended-release topiramate for …
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium.
Sperotto F, Gutiérrez-Sacristán A, Makwana S, Li X, Rofeberg VN, Cai T, Bourgeois FT, Omenn GS, Hanauer DA, Sáez C, Bonzel CL, Bucholz E, Dionne A, Elias MD, García-Barrio N, González TG, Issitt RW, Kernan KF, Laird-Gion J, Maidlow SE, Mandl KD, Ahooyi TM, Moraleda C, Morris M, Moshal KL, Pedrera-Jiménez M, Shah MA, South AM, Spiridou A, Taylor DM, Verdy G, Visweswaran S, Wang X, Xia Z, Zachariasse JM; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Newburger JW, Avillach P. Sperotto F, et al. EClinicalMedicine. 2023 Sep 14;64:102212. doi: 10.1016/j.eclinm.2023.102212. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37745025 Free PMC article.
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection. It remains unclear how MIS-C phenotypes vary across SARS-CoV-2 variants. ...All consecutive confirmed patients with MIS-C hospitalised between …
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a severe complication of SARS-CoV-2 infection. It remains unclea …
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?
Orlent H, Reynaert H, Bourgeois S, Dideberg V, Adler M, Colle I, De Maeght S, Laleman W, Michielsen P, Moreno C, Mulkay JP, Stärkel P, Delwaide J; Belgian Association for the Study of the Liver. Orlent H, et al. Acta Gastroenterol Belg. 2011 Jun;74(2):317-22. Acta Gastroenterol Belg. 2011. PMID: 21861317 Free article. Review.
Polymorphisms in the region of the interleukin-28B (IL28B) gene have recently been associated with spontaneous and treatment induced clearance of hepatitis C virus infection. The specific mechanisms of how IL28B polymorphisms affect HCV suppression remain unknown. ...
Polymorphisms in the region of the interleukin-28B (IL28B) gene have recently been associated with spontaneous and treatment induced clearan …
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL). Robaeys G, et al. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):38-45. Acta Gastroenterol Belg. 2005. PMID: 15832586 Review. No abstract available.
Alveolar proteinosis of genetic origins.
Hadchouel A, Drummond D, Abou Taam R, Lebourgeois M, Delacourt C, de Blic J. Hadchouel A, et al. Eur Respir Rev. 2020 Oct 28;29(158):190187. doi: 10.1183/16000617.0187-2019. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33115790 Free PMC article.
Campylobacter jejuni enteritis.
Baqar S, Rice B, Lee L, Bourgeois AL, El Din AN, Tribble DR, Heresi GP, Mourad AS, Murphy JR. Baqar S, et al. Clin Infect Dis. 2001 Sep 15;33(6):901-5. doi: 10.1086/322594. Epub 2001 Aug 21. Clin Infect Dis. 2001. PMID: 11512097
We report the development of Campylobacter jejuni enteritis in a patient with preexisting humoral and cellular immune recognition of C. jejuni antigens. This is one of few studies in which the immunologic status of a person with regard to C. jejuni before and after …
We report the development of Campylobacter jejuni enteritis in a patient with preexisting humoral and cellular immune recognition of C
593 results